The Impact of Inflammatory Adhesion on the Prognosis of Colon Cancer Patients
NCT ID: NCT06655285
Last Updated: 2024-11-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
229 participants
OBSERVATIONAL
2024-10-24
2024-10-27
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
the Effect of Environmental Factors on Colorectal Cancer Based on Macrogenomes
NCT06852495
Integrative Omics Analysis for Colorectal Cancer and Metastasis
NCT05482529
A Predictive Model for Recurrence of Colorectal Cancer Based on Multi-omics of Portal Vein Blood
NCT06524245
Immunological Markers Screening for Colorectal Cancer
NCT02222753
Tumor Deposits in Cancer Colon
NCT04773626
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Currently, the impact of tumor-associated inflammatory adhesion on patient prognosis is still unclear. This study aims to explore the impact of tumor-associated inflammatory adhesion on the prognosis of colon cancer patients through the Surveillance, Epidemiology, and End Results (SEER) and Chinese multi-center databases.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
the U.S. National Cancer Center SEER database
SEER\*Stat software (version 8.4.3) collected 17 registries cohort data on colon cancer patients between 2010 and 2019.
This was a retrospective study and no patient intervention was performed.
This was a retrospective study and no patient intervention was performed.
Chinese multi-center database
Chinese multi-center database includes patients from January 2010 to December 2021 at 3 institutions.
This was a retrospective study and no patient intervention was performed.
This was a retrospective study and no patient intervention was performed.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
This was a retrospective study and no patient intervention was performed.
This was a retrospective study and no patient intervention was performed.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. All patients were considered to have tumors invading adjacent organs during surgery
3. All patients underwent radical surgery.
Exclusion Criteria
18 Years
99 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jianqiang Tang
Associate professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cancer Hospital Chinese Academy of Medical Sciences
Beijing, Beijing Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NCC3650
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.